September 09, 2021
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
Media
September 02, 2021
Regulatory update from US Food and Drug Administration
August 27, 2021
Oncopeptides presents new data from OCEAN and PORT study – abstracts online
August 27, 2021
Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress
August 27, 2021
Vicore strengthens its management team
August 27, 2021
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021
August 26, 2021
Interim report April – June 2021
August 25, 2021
Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day
August 20, 2021
Oncopeptides publishes report for Q2 2021
August 18, 2021
Targovax ASA: second quarter and first half year 2021 results